Magnetic bead and magnetic bead reagent
Magnetic beads with optimized specific surface area and inorganic oxide coating efficiently extract high-purity biological substances by balancing adsorption and elution, addressing the issues of prolonged elution times and impurity incorporation in existing technologies.
Patent Information
- Application Number
- JP2023080649
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-16
- Publication Date
- 2024-11-28
AI Technical Summary
Magnetic carriers with large specific surface areas for nucleic acid binding adsorb nucleic acids non-specifically, leading to prolonged elution times and potential impurity incorporation, which can decrease the purity of the extracted nucleic acids.
Magnetic beads with a specific surface area of 0.3 to 10.0 m^2/g and a ratio of specific surface area to volume-based particle size distribution of 1.00 to 9.00, combined with a coating film containing inorganic oxide, optimize adsorption and elution efficiency while minimizing impurity adsorption.
The magnetic beads efficiently extract high-purity biological substances by ensuring sufficient adsorption and rapid elution, reducing the time required for separation and minimizing impurity contamination.
Smart Images

Figure 2024164922000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to magnetic beads and magnetic bead reagents. [Background technology]
[0002] In recent years, the demand for biological material testing has been increasing in the fields of medical diagnosis and life science. Among biological material testing methods, the PCR (Polymerase chain reaction) method is a method of extracting nucleic acids such as DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) and specifically amplifying and detecting the nucleic acids. In the process of testing such biological materials, it is first necessary to extract the substance to be tested from the specimen. A magnetic separation method using magnetic beads is widely used for this biological material extraction. In the magnetic separation method, magnetic beads that have the function of supporting the biological material to be extracted are used to extract the biological material by applying a magnetic field. Specifically, after dispersing magnetic beads whose surface has the ability to support the substance to be tested in a dispersion medium, the obtained dispersion is attached to a magnetic field generating device such as a magnetic stand, and the application of the magnetic field is repeatedly turned on and off multiple times. In this way, the substance to be tested is extracted. Since such a magnetic separation method is a method of separating and recovering magnetic beads by magnetic force, a rapid separation operation is possible.
[0003] In addition to extraction in PCR, similar magnetic separation methods are also used in the fields of protein purification, exosome and cell separation and extraction.
[0004] Patent Document 1 describes a magnetic material made of magnetic silica particles containing a superparamagnetic metal oxide, with a specific surface area of 100 to 800 m 2 / g. Such a nucleic acid-binding magnetic carrier has a large specific surface area, and therefore can non-specifically adsorb a large amount of nucleic acid. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] Japanese Patent Application Publication No. 9-19292 Summary of the Invention [Problem to be solved by the invention]
[0006] The magnetic carrier for binding nucleic acids described in Patent Document 1 has a very large specific surface area and therefore strongly adsorbs nucleic acids, which raises concerns that it may take a long time to elute the adsorbed nucleic acids.
[0007] In addition, when the specific surface area of the magnetic carrier for binding nucleic acid is large, it will take in a large amount of drugs and impurities used for the nucleic acid before adsorption. In that case, when the nucleic acid is eluted, these impurities are likely to be carried over into the eluate, and there is a concern that the purity of the extracted nucleic acid will decrease.
[0008] Therefore, the realization of magnetic beads that can efficiently extract high-purity biological materials has become a challenge. [Means for solving the problem]
[0009] The magnetic beads according to the application example of the present invention are Magnetic metal particles; a coating film that coats the surfaces of the magnetic metal particles and contains an inorganic oxide; having The specific surface area A measured by the gas adsorption method is 0.3 m 2 / g or more 10.0m 2 / g or less, The ratio A / B1 of the specific surface area A to the specific surface area B1 calculated from the volume-based particle size distribution is 1.00 or more and 9.00 or less.
[0010] The magnetic bead reagent according to the application example of the present invention is Magnetic beads according to an application example of the present invention; A dispersion medium for dispersing the magnetic beads; Contains: [Brief description of the drawings]
[0011] [Figure 1] FIG. 1 is a process diagram illustrating an example of a biological material extraction method. [Diagram 2] FIG. 2 is a schematic diagram for explaining the biological material extraction method shown in FIG. [Diagram 3] FIG. 2 is a schematic diagram for explaining the biological material extraction method shown in FIG. [Figure 4] FIG. 2 is a schematic diagram for explaining the biological material extraction method shown in FIG. [Diagram 5] FIG. 2 is a schematic diagram for explaining the biological material extraction method shown in FIG. [Figure 6] FIG. 2 is a schematic diagram for explaining the biological material extraction method shown in FIG. [Figure 7] FIG. 2 is a cross-sectional view showing a magnetic bead according to an embodiment. [Figure 8] FIG. 8 is a cross-sectional view showing a modified example of the magnetic bead of FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] Preferred embodiments of the magnetic beads and magnetic bead reagent of the present invention will now be described in detail with reference to the accompanying drawings.
[0013] The magnetic beads according to the embodiment are a particle group that adsorbs biological materials and is used for magnetic separation. Magnetic separation is a technique for separating a solid phase and a liquid phase by applying an external magnetic field to a vessel containing a solid phase including magnetic beads and a liquid phase including a dispersion medium, and magnetically attracting the solid phase.
[0014] Biological materials refer to materials such as nucleic acids such as DNA and RNA, proteins, sugars, various cells such as cancer cells, peptides, bacteria, and viruses. Nucleic acids may be present in biological samples such as cells and biological tissues, viruses, and bacteria. Such biological materials are extracted through the steps of dissolution / adsorption, washing, and elution, and are subjected to testing. By magnetically separating the magnetic beads to which the biological materials are adsorbed, the biological materials can be easily purified and extracted.
[0015] 1. Biological material extraction method An example of a method for extracting a biological material using magnetic separation will be described below. Note that in the following description, the biological material is nucleic acid.
[0016] Fig. 1 is a process diagram for explaining an example of a biological material extraction method Fig. 2 to Fig. 6 are schematic diagrams for explaining the biological material extraction method shown in Fig. 1.
[0017] The biological material extraction method shown in Fig. 1 includes a dissolving / adsorbing step S102, a washing step S108, and an elution step S110. Each step will be described below in order.
[0018] 1.1.Dissolution / adsorption process In the dissolving / adsorbing step S102, first, as shown in FIG. 2, a magnetic bead dispersion 4 (magnetic bead reagent) containing magnetic beads 2 and a dispersion medium 40 is prepared in a container 42.
[0019] In the container 42, the magnetic bead dispersion 4 is sufficiently stirred. As a result, the magnetic beads 2 are uniformly dispersed in the magnetic bead dispersion 4. After that, a predetermined amount of the magnetic bead dispersion 4 is collected from the container 42 using a pipette 44 or the like, and dispensed into the container 1 shown in FIG. 3. If the concentration distribution of the magnetic bead dispersion 4 is uniform, the desired amount of magnetic beads 2 is added to the container 1 by this dispensing operation.
[0020] Next, the specimen containing nucleic acid and the dissolving / adsorbing solution are each placed in the container 1 shown in FIG. 3. The contents of the container 1 are then mixed. As a result, the magnetic beads 2 are dispersed in the liquid 3 in the container 1, as shown in FIG. 4. Since nucleic acid is usually encapsulated in cell membranes and nuclei, the dissolving action of the dissolving / adsorbing solution dissolves and removes the so-called outer shell of the cell membrane and nucleus, and the nucleic acid is extracted. The nucleic acid is then adsorbed to the magnetic beads 2 by the adsorbing action of the dissolving / adsorbing solution.
[0021] As the dissolving / adsorbing liquid, for example, a liquid containing a chaotropic substance is used. The chaotropic substance has the effect of generating chaotropic ions in an aqueous solution, reducing the interaction of water molecules, thereby destabilizing the structure, and contributing to the adsorption of nucleic acids to the magnetic beads 2.
[0022] In addition, when extracting nucleic acids, particularly RNA, it is preferable to make the liquid 3 in the container 1 acidic by adding an acid or the like. Since RNA monomers contain ribose, they are more soluble in polar solvents than DNA. When using this difference to separate RNA and DNA, the outer shell may be dissolved and removed, and then the liquid 3 may be made acidic by adding an acid, for example. Then, a non-polar solvent such as phenol or chloroform is added to the liquid 3. This causes the DNA to move to the non-polar solvent, while the RNA remains in the polar solvent. As a result, the RNA and DNA can be separated, and the RNA can be extracted.
[0023] When extracting RNA, the pH of the liquid 3 in the container 1 is preferably 5.0 or less, more preferably 2.0 to 4.0. This causes the ionization equilibrium of the phosphate groups contained in the RNA to shift toward the hydroxyl groups, making the RNA particularly soluble in polar solvents. This can further increase the efficiency of RNA extraction.
[0024] 1.1.1.Magnetic separation operation In the dissolution / adsorption step S102, an external magnetic field is applied to the magnetic beads 2 with the nucleic acid adsorbed thereon, causing them to be magnetically attracted. This causes the magnetic beads 2 to move to the inner wall of the container 1 and to be fixed there. As a result, as shown in FIG. 5, the magnetic beads 2, which are a solid phase, can be separated from the liquid 3, which is a liquid phase. In this specification, the operation of applying such an external magnetic field to fix the magnetic beads 2 is referred to as a "magnetic separation operation."
[0025] Before performing the magnetic separation operation, the contents of the container 1 are stirred as necessary. This increases the probability that the nucleic acid will be adsorbed onto the magnetic beads 2. For stirring, for example, a vortex mixer, manual shaking, pipetting, etc. can be used.
[0026] For example, a magnet 5 disposed on the side of the container is used to apply the external magnetic field. The magnet 5 may be an electromagnet or a permanent magnet. When an external magnetic field acts on the magnetic beads 2, the magnetic beads 2 move toward the magnet 5.
[0027] 1.1.2.Liquid drain operation In the dissolution / adsorption step S102, while the magnetic beads 2 are fixed to the inner wall of the container 1, the liquid 3 accumulated at the bottom of the container 1 is aspirated and discharged using, for example, a pipette 6, as shown in Fig. 6. In this specification, such an operation of discharging the liquid 3 is referred to as a "liquid discharge operation." As a result of the liquid discharge operation, the magnetic beads 2 to which the nucleic acid is adsorbed remain in the container 1.
[0028] After the liquid discharge operation, an acceleration may be applied to the container 1 as necessary. This allows the liquid 3 adhering to the magnetic beads 2 to be shaken off, thereby reducing the amount of liquid 3 that has not been separated. The acceleration may be centrifugal acceleration. A centrifuge may be used to apply the centrifugal acceleration.
[0029] 1.2.Cleaning process In the washing step S108, the magnetic beads 2 to which the nucleic acid is adsorbed are washed. Washing refers to an operation of removing impurities adsorbed to the magnetic beads 2 by contacting the magnetic beads 2 to which the nucleic acid is adsorbed with a washing solution and then separating the magnetic beads 2 from the washing solution again to remove the impurities.
[0030] Specifically, after pouring a washing solution into the container 1 containing the magnetic beads 2 to which nucleic acid is adsorbed, the above-mentioned magnetic separation operation and liquid discharge operation are carried out again.
[0031] In the magnetic separation operation, first, a washing solution is supplied into the container 1 using a pipette or the like. Then, the magnetic beads 2 and the washing solution are stirred. As a result, the washing solution comes into contact with the magnetic beads 2, and the magnetic beads 2 to which the nucleic acid is adsorbed are washed. For stirring, for example, a vortex mixer, manual shaking, pipetting, or the like is used. At this time, the application of the external magnetic field may be temporarily turned off. This causes the magnetic beads 2 to be redispersed in the washing solution, thereby further increasing the washing efficiency.
[0032] Next, as a liquid discharge operation, the washing solution accumulated at the bottom of the container 1 is discharged while the magnetic beads 2 are fixed to the inner wall of the container 1. By supplying and discharging the washing solution as described above at least once, the magnetic beads 2 are washed. This makes it possible to remove impurities with high accuracy.
[0033] The washing liquid is not particularly limited as long as it does not promote the elution of nucleic acids and does not promote the binding of impurities to the magnetic beads 2, but examples include organic solvents such as ethanol, isopropyl alcohol, acetone, or aqueous solutions thereof, low salt concentration aqueous solutions, etc.
[0034] The washing solution may contain a surfactant such as Triton (registered trademark), Tween (registered trademark), SDS, etc. The washing solution may also contain a chaotropic substance such as guanidine hydrochloride.
[0035] Moreover, the cleaning step S108 may be performed as necessary, and may be omitted if cleaning is not necessary.
[0036] 1.3.Elution process In the elution step S110, the nucleic acid adsorbed to the magnetic beads 2 is eluted into an elution solution. Elution is an operation in which the magnetic beads 2 to which the nucleic acid is adsorbed are brought into contact with an elution solution, and then separated from the elution solution again, thereby transferring the nucleic acid to the elution solution.
[0037] Specifically, after pouring the eluate into the container 1 containing the magnetic beads 2 to which nucleic acid is adsorbed, the above-mentioned magnetic separation operation and liquid discharge operation are carried out again.
[0038] In the magnetic separation operation, first, the elution solution is supplied into the container 1 using a pipette or the like. Then, the magnetic beads 2 and the elution solution are stirred. As a result, the elution solution comes into contact with the magnetic beads 2, and the nucleic acid is eluted into the elution solution. For stirring, for example, a vortex mixer, manual shaking, pipetting, or the like is used. At this time, the application of the external magnetic field may be temporarily turned off. This causes the magnetic beads 2 to disperse in the elution solution, thereby further increasing the elution efficiency.
[0039] Next, as a liquid discharging operation, the eluate that has accumulated at the bottom of the container 1 is discharged while the magnetic beads 2 are fixed to the inner wall of the container 1. This makes it possible to collect the eluate that contains nucleic acids.
[0040] The elution liquid is not particularly limited as long as it is a liquid that promotes the elution of nucleic acid from the magnetic beads 2 to which the nucleic acid is adsorbed. For example, in addition to water such as sterile water or pure water, a TE buffer solution, i.e., an aqueous solution containing 10 mM Tris-HCl buffer and 1 mM ethylenediaminetetraacetic acid (EDTA) and having a pH of about 8, is preferably used.
[0041] The elution solution may contain a surfactant such as Triton (registered trademark), Tween (registered trademark), SDS, etc. In addition, it may contain sodium azide as a preservative.
[0042] In the elution step S110, the elution solution may be heated. This can promote the elution of the nucleic acid. The heating temperature of the elution solution is not particularly limited, but is preferably 70°C or higher and 200°C or lower, more preferably 80°C or higher and 150°C or lower, and even more preferably 95°C or higher and 125°C or lower.
[0043] 2. Magnetic Beads Next, a description will be given of the magnetic beads 2. The magnetic beads 2 are particles that are magnetic and have a surface capable of binding to a biological substance.
[0044] Fig. 7 is a cross-sectional view showing a magnetic bead 2 according to an embodiment. The magnetic bead 2 shown in Fig. 7 has magnetic metal particles 22 and a coating film 24. A magnetic metal powder is used for the magnetic metal particles 22. Therefore, the magnetic metal particles 22 are highly magnetized in a magnetic field, which contributes to improving the movement speed of the magnetic beads 2. This makes it possible to shorten the time required for magnetic separation.
[0045] In addition, since the coating film 24 contains an inorganic oxide, it has a binding property with a biological material. In addition, since the coating film 24 contains an inorganic oxide, it has a high function of protecting the magnetic metal particles 22 from oxidation, corrosion, etc. Therefore, the elution of metal ions from the magnetic beads 2 can be suppressed.
[0046] The above-mentioned magnetic separation operation uses a particle group that is an aggregate of such magnetic beads 2. In this specification, the magnetic bead 2 refers to the particle group or one of the particles that constitutes the particle group.
[0047] 2.1.Characteristics of magnetic beads 2.1.1.Specific surface area When the specific surface area of magnetic beads 2 measured by a gas adsorption method is A and the specific surface area calculated from the volume-based particle size distribution is B1, the specific surface area A and the specific surface area ratio A / B1 each satisfy the specified range described below.
[0048] Such magnetic beads 2 can ensure a sufficient amount of adsorbed biological material per unit amount. This allows efficient extraction of the biological material. It also prevents the adsorbed biological material from becoming difficult to elute. Furthermore, it prevents the introduction of drugs and impurities used in each of the above steps, and prevents a decrease in the purity of the extracted biological material. Therefore, with such magnetic beads 2, it is possible to efficiently extract high-purity biological material.
[0049] 2.1.1.1. Specific surface area A measured by gas adsorption method The specific surface area A of the magnetic beads 2 is measured, for example, according to the method for measuring the specific surface area of powders (solids) by gas adsorption as specified in JIS Z 8830:2013. An example of an apparatus used to measure the specific surface area is the BELSORP-max-N-VP-CM specific surface area and pore size distribution measuring apparatus manufactured by Microtrack-Bell. Examples of gas species used in the measurement include nitrogen and krypton.
[0050] The specific surface area A measured for magnetic beads 2 is 0.3 m 2 / g or more 10.0m 2 The specific surface area A is preferably 0.35 m 2 / g or more 4.0m 2 / g or less, and more preferably 2.0m 2 If the specific surface area A is within the above range, it is possible to ensure a sufficient amount of the biological material adsorbed per unit amount of the magnetic beads 2.
[0051] If the specific surface area A is below the lower limit, the specific surface area A is insufficient, making it impossible to ensure a sufficient amount of adsorption of the biological material. In addition, the magnetic beads 2 are more likely to settle, reducing the efficiency of adsorption of the biological material. On the other hand, if the specific surface area A is above the upper limit, a large amount of drugs and impurities other than the biological material will also be adsorbed, resulting in a decrease in the purity of the biological material ultimately extracted.
[0052] 2.1.1.2. Ratio of specific surface area A / B1 calculated from volumetric particle size distribution As described above, the specific surface area B1 of the magnetic beads 2 is a calculated value obtained from the volume-based particle size distribution of the magnetic beads 2. This calculated value is obtained as follows.
[0053] First, the particle size distribution on a volume basis is obtained for the magnetic beads 2, and an integrated distribution curve is obtained from this particle size distribution. In the obtained integrated distribution curve, the particle size at which the cumulative value from the small diameter side is 10% is defined as the representative particle size D10 of the magnetic beads 2. Similarly, the particle sizes at which the cumulative values from the small diameter side are 20%, 30%, 40%, 50%, 60%, 70%, 80%, and 90% are defined as the representative particle sizes D20, D30, D40, D50, D60, D70, D80, and D90 of the magnetic beads 2. The particle size distribution on a volume basis is obtained by a laser diffraction and dispersion method. An example of an apparatus for obtaining a particle size distribution by the laser diffraction and dispersion method is a particle size distribution measuring apparatus MT3300 series manufactured by Microtrack Bell.
[0054] Next, the volume v and surface area s are calculated for each particle with representative particle sizes D10 to D90, assuming that each particle is a sphere.
[0055] Next, the volume V occupied by each of the nine types of particle groups, each of which has a representative particle size of D10 to D90 and which constitutes 1 g of magnetic beads 2, is calculated based on the density (true specific gravity) of the magnetic beads 2. Here, it is assumed that the magnetic beads 2 are made up of nine types of particle groups with representative particle sizes D10 to D90, blended together in equal volumes. In this case, the nine types of particle groups are contained in the same volume ratio. Therefore, the volume occupied by 1 g of magnetic beads 2 is divided equally among the nine types of particle groups. For example, if the density of the magnetic beads 2 is 7 [g / cm 3 ], the volume occupied by each of the nine types of particle groups constituting 1 g of magnetic beads 2 is 1 / 7 [cm 3 / g]. Then, the volume V of each of the nine particle groups in 1 g of magnetic beads 2 is (1 / 7) / 9 [cm 3 / g].
[0056] Next, the volume V occupied by each of the nine types of particle groups constituting 1 g of the magnetic beads 2 is divided by the previously calculated volume v of one of the nine types of particles, thereby determining the number of particles n of each of the nine types of particle groups constituting 1 g of the magnetic beads 2.
[0057] Next, the previously calculated surface area s of each of the nine types of particles is multiplied by the number of particles n of each of the nine types of particle groups constituting 1 g of the magnetic beads 2. In this way, the surface area S of each particle group constituting 1 g of the magnetic beads 2 is calculated.
[0058] Next, the average value of the surface area S for each of the nine types of particle groups is calculated, and the average value obtained is multiplied by 9. This calculation result is taken as the specific surface area B1. In this manner, the specific surface area B1 of the magnetic beads 2 can be calculated.
[0059] In the magnetic beads 2 according to this embodiment, the ratio A / B1 of the specific surface area A to the specific surface area B1 calculated as described above is 1.00 or more and 9.00 or less. The ratio A / B1 is preferably 1.20 or more and 5.00 or less, more preferably 1.50 or more and 3.00 or less. If the ratio A / B1 of the specific surface areas is within the above range, the measured specific surface area A can be optimized with respect to the specific surface area B1 calculated from the particle size of the magnetic beads 2. This allows, for example, the shape of the pores of the coating film 24, such as their depth and fineness, to be optimized. The shape of the pores affects the ease of elution of the adsorbed biological material and the ease of adsorption of drugs and impurities other than the biological material. Therefore, if the ratio A / B1 of the specific surface areas is within the above range, the amount of adsorption of the biological material to the magnetic beads 2 can be sufficiently ensured, while at the same time, the ease of elution in the elution solution can be ensured. As a result, magnetic beads 2 can be obtained that can extract a sufficient amount of biological material even if the elution time is relatively short. In addition, adsorption of drugs and impurities other than the biological material can be suppressed, and a decrease in the purity of the extracted biological material can be suppressed.
[0060] If the specific surface area ratio A / B1 is below the lower limit, the manufacturing of the magnetic beads 2 becomes difficult. On the other hand, if the specific surface area ratio A / B1 exceeds the upper limit, it takes a long time to elute, or if the elute time is short, a sufficient amount of the biological material cannot be eluted. In addition, drugs and impurities other than the biological material are also extracted, reducing the purity of the extracted biological material.
[0061] The specific surface area A can be adjusted depending on the surface state of the magnetic metal particles 22, the manufacturing conditions of the coating film 24, and the like. For example, by adopting a melting process such as an atomization method as the manufacturing method for the magnetic metal particles 22, it is possible to increase the smoothness of the surface and reduce the specific surface area A without substantially changing the specific surface area B1. In this case, the ratio A / B1 can be reduced. On the other hand, by increasing the film density of the coating film 24, it is possible to reduce the specific surface area A without substantially changing the specific surface area B1. In this case, the ratio A / B1 can also be reduced.
[0062] In addition, the particle size distribution can be adjusted by classifying the produced metal powder, which allows both the specific surface areas A and B1 to be adjusted.
[0063] 2.1.1.3. Ratio of specific surface area calculated from particle size distribution based on number A / B2 When the specific surface area of the magnetic beads 2 calculated from the number-based particle size distribution is B2, it is preferable that the ratio of the specific surface areas A / B2 satisfies a predetermined range described later.
[0064] Such magnetic beads 2 have a more pronounced effect of efficiently extracting high-purity biological materials. The specific surface area B2 calculated from the number-based particle size distribution is more affected by fine particles than the specific surface area B1 described above. Therefore, even in the case of a particle size distribution in which the proportion of fine particles is relatively high, the extraction characteristics of biological materials can be further optimized by evaluating the magnetic beads 2 using the specific surface area ratio A / B2.
[0065] The specific surface area B2 of the magnetic beads 2 is a calculated value obtained from the particle size distribution based on the number of the magnetic beads 2. This calculated value is obtained as follows.
[0066] First, the particle size distribution based on the number of magnetic beads 2 is obtained, and a cumulative distribution curve is calculated from this particle size distribution. From the cumulative distribution curve obtained, the representative particle sizes D10, D20, D30, D40, D50, D60, D70, D80, and D90 of the magnetic beads 2 are calculated. The particle size distribution based on the number is calculated by a laser diffraction / dispersion method.
[0067] Next, in the same manner as in calculating the specific surface area ratio A / B1, the volume v and surface area s are calculated for each particle with representative particle sizes D10 to D90, assuming that each particle is a sphere.
[0068] Next, the volume v of each particle is summed up for the representative particle sizes D10 to D90 to determine the total volume, and the ratio r of the volume v of each particle to the total volume is calculated.
[0069] Next, the volume V occupied by each of the nine types of particle groups, each of which has a representative particle size of D10 to D90 and which constitutes 1 g of magnetic beads 2, is calculated based on the density (true specific gravity) of the magnetic beads 2. Here, it is assumed that the magnetic beads 2 are made up of nine types of particle groups with representative particle sizes D10 to D90 mixed together at the ratio r described above. Therefore, the volume occupied by 1 g of magnetic beads 2 is multiplied by the ratio r described above. For example, if the density of the magnetic beads 2 is 7 [g / cm 3 ], the volume occupied by each of the nine types of particle groups constituting 1 g of magnetic beads 2 is 1 / 7 [cm 3 / g]. Then, the volume V occupied by each of the nine types of particle groups in 1 g of magnetic beads 2 is (1 / 7) × r [cm 3 / g].
[0070] Next, the volume V occupied by each of the nine types of particle groups constituting 1 g of the magnetic beads 2 is divided by the previously calculated volume v of one of the nine types of particles, thereby determining the number of particles n of each of the nine types of particle groups constituting 1 g of the magnetic beads 2.
[0071] Next, the previously calculated surface area s of each of the nine types of particles is multiplied by the number of particles n of each of the nine types of particle groups constituting 1 g of the magnetic beads 2. In this way, the surface area S of each particle group constituting 1 g of the magnetic beads 2 is calculated.
[0072] Next, the average value of the surface area S for each of the nine types of particle groups is calculated, and the average value obtained is multiplied by 10. This calculation result is taken as the specific surface area B2. In this manner, the specific surface area B2 of the magnetic beads 2 can be calculated.
[0073] In the magnetic beads 2 according to this embodiment, the ratio A / B2 of the specific surface area A to the specific surface area B2 calculated as described above is 1.00 or more and 6.00 or less. The ratio A / B2 is preferably 1.10 or more and 3.00 or less, more preferably 1.20 or more and 2.00 or less. If the ratio A / B2 of the specific surface areas is within the above range, the measured specific surface area A can be optimized with respect to the specific surface area B2 calculated from the particle size of the magnetic beads 2. This allows, for example, the shape of the pores of the coating film 24, such as their depth and fineness, to be further optimized while taking into account the presence of fine particles. Therefore, if the ratio A / B2 of the specific surface areas is within the above range, magnetic beads 2 capable of extracting biological materials with higher purity more efficiently can be realized.
[0074] If the specific surface area ratio A / B2 is below the lower limit, the manufacturing of the magnetic beads 2 may become difficult. On the other hand, if the specific surface area ratio A / B2 exceeds the upper limit, the elution may take a long time, or if the elution time is short, a sufficient amount of the biological material may not be eluted. In addition, drugs and impurities other than the biological material may be extracted, which may reduce the purity of the extracted biological material.
[0075] 2.1.2.Magnetic properties The saturation magnetization of the magnetic beads 2 is preferably 50 emu / g or more, more preferably 80 emu / g or more, and even more preferably 100 emu / g or more. The saturation magnetization is the value of magnetization when the magnetization of the magnetic material is constant regardless of the magnetic field when a sufficiently large magnetic field is applied from the outside. If the saturation magnetization is within the above range, the function as a magnetic material can be fully exerted. Specifically, the moving speed of the magnetic beads 2 in the magnetic field can be improved, so that the time required for magnetic separation can be shortened. In addition, the saturation magnetization of the magnetic beads 2 affects the adsorption force when fixed by an external magnetic field. If the saturation magnetization is within the above range, a sufficiently high adsorption force can be obtained, so that when the liquid 3 is discharged with the magnetic beads 2 fixed, the magnetic beads 2 can be prevented from being discharged together with the liquid 3. This makes it possible to suppress the decrease in the yield of the biological material due to the decrease in the magnetic beads 2.
[0076] The upper limit of the saturation magnetization of the magnetic beads 2 is not particularly limited, but from the viewpoint of easiness in selecting a material that is suitable for balancing performance and cost, it is preferably 220 emu / g or less.
[0077] The saturation magnetization of the magnetic beads 2 can be measured by a vibrating sample magnetometer (VSM) or the like. An example of a vibrating sample magnetometer is TM-VSM1230-MHHL manufactured by Tamagawa Manufacturing Co., Ltd. The maximum applied magnetic field when measuring the saturation magnetization is, for example, 0.5 T or more.
[0078] Moreover, the coercive force Hc of the magnetic beads 2 is preferably 1500 A / m or less, more preferably 800 A / m or less, even more preferably 400 A / m or less, and particularly preferably 100 A / m or less. The coercive force Hc refers to the value of the external magnetic field in the opposite direction required to return the magnetized magnetic body to an unmagnetized state. In other words, the coercive force Hc means the resistance to the external magnetic field. The smaller the coercive force Hc of the magnetic beads 2, the less likely the magnetic beads 2 are to aggregate together even when the magnetic field is switched from an applied state to an unapplied state, and the magnetic beads 2 can be uniformly dispersed in the dispersion liquid. Furthermore, even when the application of the magnetic field is repeatedly switched, the smaller the coercive force Hc, the better the redispersibility of the magnetic beads 2, so that the aggregation of the magnetic beads 2 can be further suppressed. The lower limit of the coercive force Hc of the magnetic beads 2 is not particularly limited, but is preferably 5 A / m or more from the viewpoint of ease of material selection suitable for the balance between performance and cost.
[0079] The coercive force Hc of the magnetic beads 2 can be measured by a vibrating sample magnetometer, etc., in the same manner as the above-mentioned saturation magnetization. The maximum applied magnetic field when measuring the coercive force Hc is, for example, 15 kOe.
[0080] Moreover, the relative magnetic permeability of the magnetic beads 2 is preferably 5 or more. If the relative magnetic permeability of the magnetic beads 2 falls below the lower limit, the responsiveness of the magnetic beads 2 may decrease, and the time required for magnetic separation may become longer. The upper limit of the relative magnetic permeability of the magnetic beads 2 is not particularly limited, but since the magnetic beads 2 are in powder form, the relative magnetic permeability often takes a value of 100 or less due to the influence of the demagnetizing field.
[0081] 2.1.3. Powder characteristics The average particle diameter D50 of the magnetic beads 2 is preferably 0.5 μm or more and 15 μm or less, more preferably 1.0 μm or more and 10 μm or less, even more preferably 1.5 μm or more and 8 μm or less, and particularly preferably 2 μm or more and 6 μm or less. If the average particle diameter D50 of the magnetic beads 2 is within the above range, the specific surface area of the magnetic beads 2 can be sufficiently large, and the magnetic beads 2 can generate an attractive force and an adsorption force suitable for magnetic separation. In addition, the aggregation of the magnetic beads 2 can be suppressed and the dispersibility can be improved. If the average particle diameter D50 of the magnetic beads 2 is below the lower limit, the magnetization value of the magnetic beads 2 becomes small and the magnetic beads 2 become more likely to aggregate, which may result in a decrease in the extraction efficiency of the biological material. In addition, the moving speed of the magnetic beads 2 may decrease, and the time required for magnetic separation may become longer. On the other hand, if the average particle diameter D50 of the magnetic beads 2 exceeds the upper limit, the specific surface area of the magnetic beads 2 becomes small, so that a sufficient amount of biological material cannot be adsorbed, and the amount of biological material extracted may decrease. Furthermore, the magnetic beads 2 are more likely to settle, and the magnetic beads 2 that can contribute to the extraction of biological materials are reduced, which may result in a decrease in the efficiency of extraction of biological materials.
[0082] The average particle size D50 of the magnetic beads 2 is the particle size (median size) at which the cumulative value from the small diameter side is 50% in the cumulative distribution curve obtained from the volume-based particle size distribution described above.
[0083] In addition, when the particle diameter at which the cumulative value from the small diameter side is 90% in the cumulative distribution curve obtained from the volume-based particle size distribution is defined as the 90% particle diameter D90, the ratio D90 / D50 of the 90% particle diameter D90 to the average particle diameter D50 in the magnetic beads 2 is preferably 3.00 or less, more preferably 2.00 or less, and even more preferably 1.75 or less. This reduces the content of coarse particles, so that the coarse particles attract and aggregate with the surrounding relatively small particles, and the generation of aggregates can be suppressed. If aggregates are generated, they may settle due to their own weight, resulting in a decrease in extraction efficiency and an associated increase in the time required for testing the biological material. Therefore, if the ratio D90 / D50 is within the above range, the occurrence of these problems can be suppressed. Note that if the ratio D90 / D50 exceeds the upper limit, the content of coarse particles increases, so that even if the application of the external magnetic field is turned off, the dispersibility of the magnetic beads 2 may decrease and aggregation may occur more easily.
[0084] 2.2. Composition of magnetic beads 7, as described above, has magnetic metal particles 22 and a coating film 24. Each part will be described below.
[0085] 2.2.1.Magnetic metal particles The magnetic metal particles 22 are metal particles having magnetism, and preferably contain at least one of Fe, Co, and Ni as a constituent element, thereby obtaining magnetic beads 2 having high magnetization derived from the magnetic metal.
[0086] In particular, from the viewpoint of obtaining high saturation magnetization, the composition of the magnetic metal particles 22 is preferably an alloy mainly composed of Fe (Fe-based alloy). Specifically, it is more preferable that Fe is 50% or more in atomic ratio, and even more preferable that it is 70% or more. Examples of Fe-based alloys include Fe-Co-based alloys, Fe-Ni-based alloys, Fe-Co-Ni-based alloys, and compounds containing Fe, Co, and Ni. In addition, from the viewpoint of obtaining high magnetization, carbonyl iron powder consisting of substantially 100% by mass of Fe may be used as the magnetic metal particles 22. With such an Fe-based alloy, it is possible to realize magnetic metal particles 22 that have high saturation magnetization and high magnetic permeability even if the particle size is small. This makes it possible to realize magnetic beads 2 that have a high moving speed due to the action of an external magnetic field and a large attractive force when captured by the external magnetic field. As a result, it is possible to shorten the time required for magnetic separation, and to prevent the magnetic beads 2 themselves from being mixed into the eluate and becoming impurities.
[0087] In addition to Fe, an element that exhibits ferromagnetism by itself, as described above, Fe-based alloys can contain one or more elements selected from the group consisting of Cr, Nb, Cu, Al, Mn, Mo, Si, Sn, B, C, P, Ti, and Zr, depending on the target properties. Si is a major constituent element of alloy powders, but it is also an element that promotes amorphization.
[0088] The Fe-based alloy may contain impurities to the extent that they do not impair the effect of the magnetic metal particles 22. In this embodiment, the impurities are elements that are unintentionally mixed into the raw materials of the magnetic metal particles 22 or during the manufacture of the magnetic beads 2. The impurities are not particularly limited, but examples thereof include O, N, S, Na, Mg, and K.
[0089] An example of an Fe-based alloy is an alloy with a Si content of preferably 1.0 atomic % or more and 30.0 atomic % or less, more preferably 1.5 atomic % or more and 14.0 atomic % or less, and further preferably 2.0 atomic % or more and 7.0 atomic % or less. Such an alloy has a high magnetic permeability and therefore tends to have a high saturation magnetization.
[0090] The Fe-based alloy may also contain at least one of B (boron) with a content of preferably 5.0 atomic % to 16.0 atomic %, more preferably 8.0 atomic % to 13.0 atomic %, and C (carbon) with a content of preferably 0.5 atomic % to 5.0 atomic %, more preferably 1.5 atomic % to 4.0 atomic %. These are elements that promote amorphization and contribute to the formation of a stable amorphous structure or nanocrystalline structure in the magnetic metal particles 22. This results in magnetic metal particles 22 with low coercive force.
[0091] Furthermore, the Fe-based alloy preferably contains 1.0 atomic % or more and 8.0 atomic % or less of Cr (chromium), and more preferably contains 1.5 atomic % or more and 5.0 atomic % or less of Cr. This can improve the corrosion resistance of the magnetic metal particles 22. As a result, the magnetic metal particles 22 are obtained in which the elution of metal ions is suppressed.
[0092] The total content of impurities is preferably 1.0 atomic % or less, so that the effect of the magnetic metal particles 22 is not impaired even if impurities are contained.
[0093] The constituent elements and composition of the magnetic metal particles 22 can be identified by ICP emission spectrometry as specified in JIS G 1258:2014, spark emission spectrometry as specified in JIS G 1253:2002, or the like. In addition, when the magnetic metal particles 22 are coated with a coating film 24, the coating film 24 can be removed by a chemical or physical method, and then the above-mentioned method can be used for measurement. In addition, when it is difficult to remove the coating film 24, for example, the magnetic beads 2 can be cut, and the core part of the magnetic metal particle 22 can be analyzed by an analyzer such as an EPMA (Electron Probe Micro Analyzer) or EDX (Energy Dispersive X-ray spectroscopy).
[0094] The Vickers hardness of the magnetic metal particles 22 is preferably 100 or more, more preferably 300 or more, and even more preferably 800 or more. The method for measuring the hardness of the magnetic metal particles 22 is, for example, as follows. A plurality of magnetic metal particles 22 are taken out and embedded in resin to prepare a resin-embedded sample, and then the cross section of the magnetic metal particles 22 is made to appear on the surface of the resin-embedded sample by grinding and polishing. An indentation is made on this using a micro Vickers tester or a nano indenter, and the hardness is measured from the size of the indentation.
[0095] If the Vickers hardness of the magnetic metal particles 22 is less than the lower limit, the magnetic metal particles 22 may be plastically deformed due to the impact of the collision of the magnetic beads 2. If plastic deformation occurs, the coating film 24 may peel off or fall off. The upper limit of the Vickers hardness is not particularly limited, but is preferably 3000 or less from the viewpoint of ease of material selection suitable for the balance between performance and cost.
[0096] The main metal structure constituting the magnetic metal particles 22 can take various forms such as a crystalline structure, an amorphous structure, a nanocrystalline structure, and the like. An amorphous structure is a non-crystalline structure in which no crystals exist, and a nanocrystalline structure refers to a structure mainly composed of fine crystals with a crystal grain size of 100 nm or less. The amorphous structure and the nanocrystalline structure give the magnetic metal particles 22 high hardness. In addition, by making the magnetic beads 2 into an amorphous structure or a nanocrystalline structure, the coercive force Hc of the magnetic beads 2 becomes a particularly low value, which contributes to improving the redispersibility of the magnetic beads 2. The volume fraction of the amorphous structure or the nanocrystalline structure in the magnetic metal particles 22 is preferably 40% or more, more preferably 60% or more. This volume fraction is obtained from the results of crystal structure analysis by X-ray diffraction. In addition, the crystalline structure, the amorphous structure, and the nanocrystalline structure may each exist alone, or two or more of them may be mixed.
[0097] The metal structure of the magnetic metal particles 22 can be identified by performing crystal structure analysis on the magnetic metal particles 22 by X-ray diffraction. Furthermore, it can be specified by analyzing the structure observation image or diffraction pattern of the cut sample by a transmission electron microscope (TEM). For example, in the case of an amorphous structure, a diffraction peak derived from a metal crystal such as an α-Fe phase is not observed in a peak analysis by X-ray diffraction. In addition, in the case of an amorphous structure, a so-called halo pattern is formed in an electron beam diffraction pattern by TEM, and the formation of spots due to crystals is not observed. A nanocrystalline structure is composed of a crystalline structure with a grain size of, for example, 100 nm or less, and can be confirmed from a TEM observation image. More accurately, the average grain size can be calculated by image processing or the like from multiple TEM structure observation images in which multiple crystals exist. In addition, the crystal grain size can be estimated by the Scherrer method from the diffraction peak of the target crystalline phase by X-ray diffraction. Furthermore, for a crystalline structure with a large grain size, the crystal grain size can be measured by a method such as observing a cross section with an optical microscope or a scanning electron microscope (SEM).
[0098] In order to obtain the amorphous structure and nanocrystalline structure, it is effective to increase the cooling rate when pulverizing the molten raw material and then cooling it when manufacturing the magnetic metal particles 22. The ease of forming the amorphous structure and nanocrystalline structure also depends on the alloy composition. As a specific alloy system suitable for forming the amorphous structure and nanocrystalline structure, a composition in which one or more elements selected from the group consisting of Cr, Si, B, C, P, Nb, and Cu are added to Fe is preferable.
[0099] The magnetic metal particles 22 are manufactured by a method similar to a general method for manufacturing metal powder. Examples of manufacturing methods include a melting process in which a metal is melted and solidified to produce a powder, a chemical process in which a powder is produced by a reduction method or a carbonyl method, and a mechanical process in which a larger object such as an ingot is mechanically crushed to obtain a powder. Of these, the melting process is suitable for manufacturing the magnetic metal particles 22.
[0100] Among the manufacturing methods using the melting process, atomization is a representative manufacturing method. In the atomization method, a molten metal is collided with a fluid (liquid or gas) sprayed at high speed to rapidly cool and solidify it into powder, and depending on the type of coolant and the configuration of the device, it can be divided into water atomization, high-pressure water atomization, rotating water flow atomization, gas atomization, etc. According to the atomization method, the magnetic metal particles 22 can be efficiently manufactured. Furthermore, in the high-pressure water atomization method, rotating water flow atomization method, and gas atomization method, the particle shape of the metal powder becomes close to a spherical shape due to the action of surface tension.
[0101] In particular, by increasing the heating temperature of the molten metal by preferably 100°C or more, more preferably 150°C or more, higher than the melting point of the raw material, the spheroidization during rapid solidification can be promoted. The spheroidization can reduce the specific surface area of the magnetic metal particles 22. As a result, the specific surface area A of the magnetic beads 2 can be reduced.
[0102] 2.2.2.Coating film The coating film 24 covers the particle surface of the magnetic metal particle 22 as shown in Fig. 7. The coating film 24 may be formed on at least a part of the particle surface of the magnetic metal particle 22, but it is preferable that the coating film 24 covers the entire particle surface.
[0103] The coating film 24 coats the particle surfaces of the magnetic metal particles 22 and contains an inorganic oxide. Examples of inorganic oxides include silicon oxide, magnesium oxide, calcium oxide, aluminum oxide, titanium oxide, zirconium oxide, boron oxide, and yttrium oxide, and one or a mixture of two or more of these is used. The coating film 24 containing such an inorganic oxide is porous, and therefore has a large specific surface area. This allows the coating film 24 to adsorb a larger amount of biological material.
[0104] In addition, the inorganic oxide is preferably silicon oxide. Silicon oxide enables efficient extraction and recovery of biological substances by specifically adsorbing biological substances such as nucleic acids in the dissolution and adsorption solution. Furthermore, since silicon oxide is chemically stable, it can particularly suppress the oxidation and corrosion of the magnetic metal particles 22, and can particularly enhance the corrosion resistance of the magnetic beads 2.
[0105] Silicon oxide is represented by the composition formula SiOx (0 < x ≤ 2), preferably SiO2. In addition, silicon oxide may form a composite oxide or a composite with one or more selected from the group consisting of Al, Ti, V, Nb, Cr, Mn, Sn, and Zr.
[0106] The inorganic oxide may contain substances (impurities) other than the inorganic oxide within a range that does not impair the above effects. For example, it may contain them at a ratio such that the preferably 50 mass% or less, more preferably 10 mass% or less of the aforementioned inorganic oxide. For example, when silicon oxide is used as the inorganic oxide, examples of the impurities include C, N, P, etc. The composition of the inorganic oxide can be confirmed by, for example, EDX analysis, Auger electron spectroscopy measurement, etc.
[0107] The average thickness of the coating film 24 is preferably 10 nm or more, more preferably 20 nm or more, and even more preferably 30 nm or more. Thereby, even if collisions occur between the magnetic beads 2 or with the inner wall of the container etc., it is possible to suppress the coating film 24 from being broken or peeled off. As a result, it is possible to suppress the elution of metal ions etc. accompanying the exposure of the magnetic metal particles 22. On the other hand, the average thickness of the coating film 24 is preferably 500 nm or less, more preferably 200 nm or less, and even more preferably 150 nm or less. Thereby, it is possible to suppress a decrease in the magnetization per volume of the magnetic beads 2 and suppress a decrease in the moving speed of the magnetic beads 2.
[0108] In addition, when the average thickness of the coating film 24 is t and the average particle size of the magnetic beads 2 is D50, the ratio of t to D50, t / D50, is preferably 0.0005 to 0.2, more preferably 0.001 to 0.05, and even more preferably 0.005 to 0.03. If t / D50 is below the lower limit, the ratio of the thickness of the coating film 24 to the size of the magnetic metal particles 22 becomes too small, so that the coating film 24 may be destroyed or peeled off when the magnetic beads 2 collide with each other or with the inner wall of the container 1. This may reduce the amount of biological material adsorbed to the surface of the coating film 24 and extracted, and may reduce the extraction efficiency. In addition, if the peeled coating film 24 or pieces of the magnetic metal particles 22 are present in the extraction liquid, they may be mixed in as contaminants when the biological material is extracted. Furthermore, the magnetic metal particles 22 are exposed when the coating film 24 is destroyed or peeled off, and when the magnetic metal particles 22 come into contact with an acidic solution, metal ions and the like are eluted, which may result in a decrease in the efficiency of extraction of biological materials. On the other hand, when t / D50 exceeds the upper limit, the volume ratio of the coating film 24 to the total volume of the magnetic beads 2 increases, and the magnetization per volume of the magnetic beads 2 may decrease. This may reduce the movement speed when an external magnetic field is applied to the magnetic beads 2, and may increase the time required for magnetic separation.
[0109] The thickness of the coating film 24 can be measured from, for example, a cross-sectional observation image of the magnetic beads 2 by a transmission electron microscope or a scanning electron microscope. The average thickness t of the coating film 24 can be calculated by obtaining a plurality of observation images and averaging the measured values obtained by image processing or the like. For example, the average thickness t is a value obtained by measuring the thickness of the coating film 24 at five or more points on one magnetic bead 2, calculating the average value, and then averaging the average values for ten or more magnetic beads 2. Also, an analyzer such as EDX (Energy Dispersive X-ray spectroscopy) may be used to compare the intensities of, for example, Si-K characteristic X-rays and Fe-L characteristic X-rays, and the thickness of the coating film 24 may be calculated from the comparison result. That is, as described later, when the coating film 24 contains silicon and the magnetic metal particles 22 are made of an Fe-based alloy, the intensity ratio of the Si-K characteristic X-rays originating from the coating film 24 to the sum of the Fe-L characteristic X-rays originating from the magnetic metal particles 22 and the Si-K characteristic X-rays originating from the coating film 24 can be converted into the thickness of the coating film 24.
[0110] Examples of the method for forming the coating film 24 include a wet method such as a sol-gel method and a dry method such as a vapor phase deposition method. Among these, the Stober method, which is a type of sol-gel method, and the ALD (Atomic Layer Deposition) method can be preferably used. The Stober method is a method for forming monodisperse particles by hydrolysis of metal alkoxide. For example, when the coating film 24 is formed of silicon oxide, silicon oxide can be produced by a hydrolysis reaction of silicon alkoxide. Before forming the coating film 24, a cleaning treatment using water or an organic solvent may be performed on the base, for example, the surfaces of the magnetic metal particles 22.
[0111] An example of the film formation conditions for the coating film 24 by the Stöber method using silicon alkoxide will be given below.
[0112] The rate of addition of silicon alkoxide is, for example, 1 m of surface area of the magnetic metal particles 22. 2In terms of the amount per unit of addition, a rate of 0.00010 mol / h or more and 0.00100 mol / h or less is preferable, and a rate of 0.00016 mol / h or more and 0.00064 mol / h or less is more preferable. At such an addition rate, a silicon oxide coating film with higher density and smaller specific surface area A can be formed.
[0113] The deposition rate of the silicon oxide film is preferably 1 nm / h to 50 nm / h, more preferably 5 nm / h to 20 nm / h. At such a deposition rate, a silicon oxide film with higher density and smaller specific surface area A can be efficiently formed.
[0114] The density of the silicon oxide coating is not particularly limited, but is preferably 1.7 g / cm 3 More than 2.2g / cm 3 It is preferable that the density is 1.8 g / cm or less. 3 More than 2.1g / cm 3 It is more preferable that the density of the silicon oxide coating is within the above range. By setting the density of the silicon oxide coating within the above range, it becomes easier to keep the specific surface area ratios A / B1 and A / B2 within the above range. In other words, it becomes possible to form a coating film 24 with optimized pore shape and density.
[0115] The coating film 24 may cover the surface of one magnetic metal particle 22, but may also cover a plurality of magnetic metal particles 22 collectively.
[0116] FIG. 8 is a cross-sectional view showing a modified example of the magnetic bead 2 of FIG. The magnetic beads 2A shown in Fig. 8 contain a plurality of magnetic metal particles 22. A coating film 24 is provided so as to cover the plurality of magnetic metal particles 22. With such magnetic beads 2A, the same effect as with the magnetic beads 2 shown in Fig. 7 can be obtained.
[0117] The number of magnetic metal particles 22 that the magnetic beads 2A have is not particularly limited, but is set to be 2 or more and 100 or less.
[0118] 3. Magnetic bead dispersion Next, the magnetic bead dispersion 4 according to the embodiment will be described. The magnetic bead dispersion 4 shown in Fig. 2 contains the magnetic beads 2 and a dispersion medium 40, as described above.
[0119] Examples of the dispersion medium 40 include water, saline, polar organic solvents such as alcohols, or aqueous solutions thereof. Examples of water include sterilized water, pure water, etc. Examples of alcohols include ethanol, isopropyl alcohol, etc.
[0120] The concentration of the magnetic beads 2 in the magnetic bead dispersion 4 is not particularly limited as long as the magnetic bead dispersion 4 can be sufficiently uniformly stirred.
[0121] A surfactant may be added for the purpose of improving the dispersibility of the magnetic beads 2 in the magnetic bead dispersion liquid 4. Examples of the surfactant include nonionic surfactants, cationic surfactants, anionic surfactants, and amphoteric surfactants.
[0122] Examples of nonionic surfactants include Triton surfactants such as Triton (registered trademark)-X, Tween surfactants such as Tween (registered trademark) 20, and acylsorbitan. Examples of cationic surfactants include dodecyltrimethylammonium bromide, dodecyltrimethylammonium chloride, and cetyltrimethylammonium bromide. Examples of anionic surfactants include sodium dodecyl sulfate, sodium N-lauroyl sarcosine (SDS), sodium cholate, sodium lauryl sulfate, and sarcosine. Examples of amphoteric surfactants include phosphatidylethanolamine. These surfactants may be used alone or in combination of two or more.
[0123] The content of the surfactant in the magnetic bead dispersion 4 is preferably equal to or greater than the critical micelle concentration of the surfactant. The critical micelle concentration, also called CMC (critical micelle concentration), refers to the concentration at which the surfactant molecules dispersed in the liquid aggregate to form micelles. When the content of the surfactant is equal to or greater than the critical micelle concentration, the surfactant is more likely to form a layer around the magnetic beads 2. This can further enhance the effect of suppressing aggregation of the magnetic beads 2.
[0124] The surfactant content is not limited to the critical micelle concentration or more, and may be less than the critical micelle concentration. For example, the surfactant content in the magnetic bead dispersion 4 is preferably 0.05% by mass or more and 3.0% by mass or less, regardless of the critical micelle concentration.
[0125] Furthermore, it is preferable to add a preservative to provide long-term storage stability and preservative effect to the magnetic bead dispersion 4. Examples of preservatives include sodium azide. The concentration of the preservative added is preferably 0.02% by mass or more and less than 0.1% by mass of the magnetic bead dispersion 4. If it is less than 0.02% by mass, there is a risk that sufficient long-term storage stability and preservative effect cannot be obtained, and if it is 0.1% by mass or more, there is a risk that problems such as a decrease in the extraction efficiency of biological materials may occur.
[0126] A buffer solution may be added for the purpose of adjusting the pH, such as Tris buffer.
[0127] 4. Advantages of the above embodiment As described above, the magnetic beads 2 according to the embodiment have the magnetic metal particles 22 and the coating film 24. The coating film 24 coats the surfaces of the magnetic metal particles 22 and contains an inorganic oxide. When the specific surface area of the magnetic beads 2 measured by a gas adsorption method is A and the specific surface area calculated from the volume-based particle size distribution is B1, the specific surface area A of the magnetic beads 2 is 0.3 m 2 / g or more 10.0m 2 / g or less, and the ratio A / B1 of the specific surface area A to the specific surface area B1 is 1.00 or more and 9.00 or less.
[0128] According to this configuration, the specific surface area A is optimized, so that the amount of biological material adsorbed per unit amount of magnetic beads 2 can be sufficiently ensured. Furthermore, the ratio A / B1 is also optimized, so that the amount of biological material adsorbed to the magnetic beads 2 can be sufficiently ensured while at the same time ensuring ease of elution in the elution liquid. As a result, magnetic beads 2 are obtained that can extract a sufficient amount of biological material even if the elution time is relatively short. Furthermore, adsorption of drugs and impurities other than the biological material can be suppressed, and a decrease in the purity of the biological material to be extracted can be suppressed. Therefore, according to the above configuration, magnetic beads 2 that can efficiently extract high-purity biological material can be obtained.
[0129] The inorganic oxide is preferably silicon oxide. Silicon oxide is chemically stable, and therefore can particularly inhibit oxidation and corrosion of the magnetic metal particles 22, thereby particularly enhancing the corrosion resistance of the magnetic beads 2. Silicon oxide also specifically adsorbs biological materials such as nucleic acids in a dissolution / adsorption solution, thereby enabling efficient extraction and recovery of the biological materials.
[0130] Furthermore, the ratio A / B2 of the specific surface area A to the specific surface area B2 calculated from the number-based particle size distribution is preferably 1.00 or more and 6.00 or less.
[0131] According to this configuration, it is possible to obtain magnetic beads 2 capable of extracting biological material with higher purity and more efficiently.
[0132] Moreover, the magnetic metal particles 22 are preferably made of an Fe-based alloy. With this configuration, it is possible to realize magnetic metal particles 22 that have high saturation magnetization and high magnetic permeability even if they have a small particle size. This makes it possible to realize magnetic beads 2 that have a high migration speed due to the action of an external magnetic field and a large attractive force when captured by the external magnetic field. As a result, it is possible to shorten the time required for magnetic separation, and to prevent the magnetic beads 2 themselves from being mixed into the eluate and becoming impurities.
[0133] Moreover, the Fe-based alloy preferably contains an amorphous structure. According to this configuration, magnetic beads 2 with low coercive force and excellent redispersibility are obtained.
[0134] In addition, in an integrated distribution curve obtained from the volume-based particle size distribution, the particle size D50, at which the cumulative value from the small diameter side is 50%, is preferably 0.5 μm or more and 15 μm or less.
[0135] According to this configuration, the specific surface area of the magnetic beads 2 can be made sufficiently large, and the magnetic beads 2 can generate attractive and adsorbing forces suitable for magnetic separation. In addition, aggregation of the magnetic beads 2 can be suppressed, and dispersibility can be improved.
[0136] Furthermore, the ratio t / D50 of the average thickness t of the coating film 24 to the particle diameter D50 is preferably 0.0005 or more and 0.2 or less.
[0137] With this configuration, peeling of the coating film 24 due to collision of the magnetic beads 2 can be suppressed. Also, elution of metal ions and the like can be suppressed. Furthermore, a decrease in magnetization per volume of the magnetic beads 2 can be suppressed. As a result, magnetic separation can be performed more quickly, and magnetic beads 2 with higher extraction efficiency of biological materials can be obtained.
[0138] Moreover, the magnetic bead dispersion 4 as the magnetic bead reagent according to the embodiment contains the magnetic beads 2 and a dispersion medium 40 in which the magnetic beads 2 are dispersed.
[0139] According to this configuration, the magnetic metal particles 22 have high magnetization derived from the magnetic metal, so that the magnetic bead dispersion 4 can be obtained with a high migration speed under the action of an external magnetic field and rapid magnetic separation. In addition, the metal ion concentration of the supernatant obtained by subjecting it to the above operation is optimized, so that the magnetic bead dispersion 4 with high extraction efficiency of biological materials can be obtained.
[0140] Although the magnetic beads and magnetic bead reagent of the present invention have been described above based on the illustrated embodiment, the present invention is not limited thereto. For example, the magnetic beads and magnetic bead reagent of the present invention may be those having any component added thereto in the above embodiment. EXAMPLES
[0141] Next, specific examples of the present invention will be described. 5. Preparation of Magnetic Beads First, magnetic metal particles composed of soft magnetic materials A to D having the compositions shown in Table 1 were produced by high-pressure water atomization. The metal structures of the obtained magnetic metal particles were then analyzed by X-ray diffraction. The metal structures identified by the analysis are shown in Table 1. Soft magnetic materials E and F were ferrite (nonmetallic soft magnetic material).
[0142] [Table 1]
[0143] Next, a silicon oxide (SiO2) film was formed on the surface of the magnetic metal particles by the Stöber method to obtain a coating film. In the Stöber method, first, 100 g of magnetic metal powder was dispersed and mixed in 950 mL of ethanol, and the mixture was stirred for 20 minutes by an ultrasonic application device. After stirring, a mixed solution of 30 mL of pure water and 180 mL of ammonia water was added and stirred for another 10 minutes. Then, a mixed solution of tetraethoxysilane (TEOS) and 100 mL of ethanol was further added and stirred to form a coating film on the surface of the magnetic metal particles. Note that the formation time in this case was 30 minutes, but the formation time was changed depending on the thickness to be formed. In addition, the addition rate of TEOS in this case was appropriately adjusted within the range of 0.00016 mol / h to 0.00064 mol / h. Furthermore, the film formation rate of the coating film was appropriately adjusted within the range of 5 nm / h to 20 nm / h. Then, the obtained coating film was washed with ethanol and acetone, respectively. After washing, the beads were dried at 65° C. for 30 minutes and then heated at 200° C. for 90 minutes. As a result, magnetic beads of Samples No. 1 to 18 shown in Tables 2 and 3 were obtained. The saturation magnetization and coercive force of the magnetic beads are as shown in Tables 2 and 3.
[0144] 6. Measurement of specific surface area A The specific surface area A of the magnetic beads of Samples No. 1 to 18 was measured by the method described above. The measurement results are shown in Tables 2 and 3.
[0145] In Tables 2 and 3, magnetic beads corresponding to the present invention are designated as "Examples", and magnetic beads not corresponding to the present invention are designated as "Comparative Examples".
[0146] 7. Calculation of specific surface areas B1 and B2 The volumetric particle size distribution and number-based particle size distribution of the magnetic beads of Samples No. 1 to 18 were measured. A Microtrack Bell MT3300 series particle size distribution analyzer was used for the measurements. Next, the specific surface areas B1 and B2 were calculated using the above-mentioned calculation method based on the obtained particle size distribution and the density shown in Table 1. In addition, the ratio A / B1 of the specific surface area A to the specific surface area B1, and the ratio A / B2 of the specific surface area A to the specific surface area B2 were calculated. The calculation results are shown in Tables 2 and 3.
[0147] [Table 2]
[0148] [Table 3]
[0149] 8. Extraction of Nucleic Acids Using Magnetic Beads In Examples 1 to 12 shown in Table 4, nucleic acid extraction was performed using magnetic beads of Samples No. 1 to 4. In Comparative Examples 1 to 12 shown in Table 4, nucleic acid extraction was performed using magnetic beads of Samples No. 5 to 8. In Examples 13 to 18 shown in Table 5, nucleic acid extraction was performed using magnetic beads of Samples No. 9 to 14. In Comparative Examples 13 to 16 shown in Table 5, nucleic acid extraction was performed using magnetic beads of Samples No. 15 to 18.
[0150] The nucleic acid extraction method is as follows. First, human genomic DNA was prepared as a model nucleic acid, and lysozyme was prepared as a model impurity.
[0151] Next, the magnetic beads of each Example and Comparative Example were dispersed in pure water and stirred to prepare a magnetic bead suspension. The magnetic bead content in the magnetic bead suspension was set to 53.17% by mass.
[0152] Next, the reagents other than the nucleic acid were left to cool to room temperature, and then the reagents were added to the tube in the following order:
[0153] ·Pure water 65μL ·20μL of nucleic acid dispersion with a concentration of 0.1μg / μL ·Dissolved adsorption solution 750μL 15μL of lysozyme solution with a concentration of 10μg / μL ·Magnetic bead suspension 40μL
[0154] Next, the contents of the tube were mixed with a vortex mixer for 10 minutes, and then the tube was placed on a magnetic stand and left for 30 seconds. Then, when the magnetic beads were magnetically collected, the supernatant was removed.
[0155] Next, 900 μL of washing solution was added to the tube, and the tube was stirred with a vortex mixer for 5 seconds and then centrifuged. The tube was then placed on a magnetic stand and left for 30 seconds. Once the magnetic beads were magnetically captured, the supernatant was removed. After that, the addition of washing solution, magnetic capture, and removal of the supernatant were repeated once more.
[0156] Next, 900 μL of 70% ethanol in water was added to the tube, and the tube was stirred with a vortex mixer for 5 seconds and then centrifuged. The contents of the tube were then pipetted back in once. The tube was then placed on a magnetic stand and left for 30 seconds. Once the magnetic beads were magnetically captured, the supernatant was removed. The ethanol in water solution was then added, magnetically captured, and the supernatant was removed once more. The tube was then centrifuged, and the remaining supernatant was removed.
[0157] Next, 100 μL of pure water was added to the tube, and the tube was stirred with a vortex mixer to elute the nucleic acid. At this time, the stirring time with the vortex mixer was set to the elution time shown in Tables 4 and 5. The tube was then placed on a magnetic stand and left for 30 seconds. Then, when the magnetic beads were magnetically collected, the eluate containing the nucleic acid was collected in a separate tube.
[0158] 9. Evaluation of extracted nucleic acids The nucleic acids extracted in each of the Examples and Comparative Examples were evaluated by the following method.
[0159] 9.1. Nucleic acid yield For the eluate containing the extracted nucleic acid, the yield of nucleic acid was calculated by the following method.
[0160] First, the tube containing the recovered eluate was placed in an absorptiometer, and the concentration of nucleic acid in the eluate was quantified from the absorbance at a wavelength of 260 nm. Since nucleic acid bases have an absorption maximum near 260 nm, the absorbance at a wavelength of 260 nm was used to quantify the concentration of nucleic acid. The amount of nucleic acid recovered was calculated from the concentration obtained, and the ratio of the amount of nucleic acid recovered to the amount of nucleic acid input was calculated as the yield. The calculation results are shown in Tables 4 and 5.
[0161] The calculated yield of nucleic acid was evaluated based on the following evaluation criteria. The evaluation results are shown in Tables 4 and 5 as relative evaluation of yield.
[0162] A: The nucleic acid yield is 80% or more. B: The nucleic acid yield is 65% or more but less than 80%. C: Nucleic acid yield is 50% or more but less than 65% D: Nucleic acid yield is less than 50%
[0163] 9.2. Nucleic Acid Purity The absorbance A260 at a wavelength of 260 nm of the eluate containing the extracted nucleic acid was measured by the method shown in 9.1. Also, the absorbance A280 at a wavelength of 280 nm was measured.
[0164] Next, the ratio A260 / A280 of the absorbance A260 to the absorbance A280 was calculated. The calculation results are shown in Tables 4 and 5 as the purity of the nucleic acid.
[0165] The calculation results were evaluated according to the following evaluation criteria. The evaluation results are shown in Tables 4 and 5 as relative evaluations of purity.
[0166] A: The ratio A260 / A280 is 1.7 or more and 1.9 or less. B: The ratio A260 / A280 is less than 1.7 or more than 1.9
[0167] [Table 4]
[0168] [Table 5]
[0169] As shown in Tables 4 and 5, it was confirmed that the use of the magnetic beads of each Example made it possible to extract nucleic acids with a high yield even in a short extraction time. It was also confirmed that the use of the magnetic beads of each Example made it possible to extract nucleic acids with high purity. From the above results, it was confirmed that the magnetic beads and magnetic bead reagent of the present invention made it possible to efficiently extract biological materials with high purity. [Explanation of symbols]
[0170] 1...container, 2...magnetic beads, 2A...magnetic beads, 3...liquid, 4...magnetic bead dispersion, 5...magnet, 6...pipette, 22...magnetic metal particles, 24...coating film, 40...dispersion medium, 42...container, 44...pipette, S102...dissolution / adsorption process, S108...washing process, S110...elution process
Claims
1. Magnetic metal particles; a coating film that coats the surfaces of the magnetic metal particles and contains an inorganic oxide; having The specific surface area A measured by gas adsorption method is 0.3 m 2 / g or more 10.0m 2 / g or less, Magnetic beads, characterized in that the ratio A / B1 of the specific surface area A to the specific surface area B1 calculated from a volume-based particle size distribution is 1.00 or more and 9.00 or less.
2. The magnetic beads according to claim 1 , wherein the inorganic oxide is silicon oxide.
3. 3. The magnetic beads according to claim 1, wherein the ratio A / B2 of the specific surface area A to the specific surface area B2 calculated from the number-based particle size distribution is 1.00 or more and 6.00 or less.
4. 3. The magnetic beads according to claim 1, wherein the magnetic metal particles are made of an Fe-based alloy.
5. The magnetic beads according to claim 4 , wherein the Fe-based alloy includes an amorphous structure.
6. 3. The magnetic beads according to claim 1, wherein a particle diameter D50, at which a cumulative value from the small diameter side is 50% in an integrated distribution curve obtained from a volume-based particle size distribution, is 0.5 μm or more and 15 μm or less.
7. 7. The magnetic beads according to claim 6, wherein the ratio t / D50 of the average thickness t of the coating film to the particle diameter D50 is 0.0005 or more and 0.2 or less.
8. The magnetic beads according to claim 1 or 2, A dispersion medium for dispersing the magnetic beads; A magnetic bead reagent comprising:
Citation Information
Patent Citations
Magnetic carrier for binding nucleic acid and nucleic acid isolation using the same
JP1997019292A
